|
|
Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.
More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.
This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.
Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.
Earwax has antimicrobial properties that reduce the viability of bacteria and fungus in the human ear.